The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York AOD 9604 G Lab Peptides FDA Peptide Reclassification 2026: What It Means for Providers AOD 9604: The Complete Evidence Based Guide to the F NinjAthlete AOD9604 Oath Research